Meal-induced platelet activation in diabetes mellitus type 1 or type 2 is related to postprandial insulin rather than glucose levels.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Thrombosis Research

• Publication date

  2016-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.thromres.2016.03.009PMID 26994470
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Glucose‐lowering with exogenous insulin monotherapy in type 2 diabetes: dose association with all‐cause mortality, cardiovascular events and cancer

  2015cited by this paper
• Insulin Therapy in People With Type 2 Diabetes: Opportunities and Challenges?

  2014cited by this paper
• Association between intensification of metformin treatment with insulin vs sulfonylureas and cardiovascular events and all-cause mortality among patients with diabetes.

  2014cited by this paper
• Platelet Function Profiles in Patients with Diabetes Mellitus

  2013cited by this paper
• Long-term mortality in patients with type 2 diabetes undergoing coronary angiography: the impact of glucose-lowering treatment

  2012cited by this paper
• Postprandial Platelet Activation Is Related to Postprandial Plasma Insulin Rather Than Glucose in Patients With Type 2 Diabetes

  2012cited by this paper
• Endogenous hyperinsulinaemia and exogenous insulin: a common theme between atherosclerosis, increased cancer risk and other morbidities.

  2012cited by this paper
• Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus

  2010cited by this paper
• Platelet Tissue Factor Synthesis in Type 2 Diabetic Patients Is Resistant to Inhibition by Insulin

  2010cited by this paper
• The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial.

  2007cited by this paper
• Platelet activation and atherothrombosis.

  2007cited by this paper
• Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study.

  2006cited by this paper
• Meal‐induced platelet activation in Type 2 diabetes mellitus: effects of treatment with repaglinide and glibenclamide

  2006cited by this paper
• Platelet Inhibition by Insulin Is Absent in Type 2 Diabetes Mellitus

  2005cited by this paper
• The post‐prandial state in Type 2 diabetes and endothelial dysfunction: effects of insulin aspart

  2004cited by this paper
• Inhibition of Platelet‐Collagen Interaction An In Vivo Action of Insulin Abolished by Insulin Resistance in Obesity

  2002cited by this paper
• Insulin, but not proinsulin C-peptide, enhances platelet fibrinogen binding in vitro in Type 1 diabetes mellitus patients and healthy subjects.

  2002cited by this paper
• Insulin enhances platelet activation in vitro.

  2001cited by this paper
• Efficient flow cytometric assay for platelet-leukocyte aggregates in whole blood using fluorescence signal triggering.

  1999cited by this paper
• Evidence for prothrombotic effects of exercise and limited protection by aspirin.

  1999cited by this paper

• Research advances on whole grains benefit on metabolic syndrome via gut homeostasis regulation.

  2026cites this paper
• Association between Relative Thrombocytosis and Microalbuminuria in Adults with Mild Fasting Hyperglycemia

  2024cites this paper
• Acute Antiplatelet Effects of an Oleocanthal-Rich Olive Oil in Type II Diabetic Patients: A Postprandial Study

  2024cites this paper
• The postprandial actions of GLP-1 receptor agonists: The missing link for cardiovascular and kidney protection in type 2 diabetes.

  2023cites this paper
• Platelet Effects of Anti-diabetic Therapies: New Perspectives in the Management of Patients with Diabetes and Cardiovascular Disease

  2021cites this paper
• Possible association between haemostasis dysfunction and early onset of microvascular complications in patients with type 1 diabetes.

  2020cites this paper
• Meal intake increases circulating procoagulant microparticles in patients with type 1 and type 2 diabetes mellitus

  2019cites this paper
• Hemostasis, endothelial stress, inflammation, and the metabolic syndrome

  2017cites this paper
• Circulating MiRNA biomarkers serve as a fingerprint for diabetic atherosclerosis.

  2016cites this paper